Story excerpt provided by Business Wire
New Directions Technology Consulting, LLC (New Directions), and mHealth application service provider iRx Reminder, LLC, have signed an invention promotion agreement to expand iRx Reminder’s bidirectional smartphone-based solutions focused on improving real-time data collection and lowering costs of clinical trials.
Under the nonexclusive agreement, effective April 4, 2013, the companies will collaborate on the development of software and devices that incorporate the intellectual property of iRx Reminder and the mMed mobile medication management patent portfolio, for which New Directions is the exclusive market developer.
“Combining our patented technologies with the mMed portfolio will let us enhance our SaaS mobile health offering, which already has been shown to reduce dropout rates, improve data accuracy and speed up completion times of clinical trials,” said iRx Reminder founder and CEO Anthony Sterns, Ph.D.
Read the complete article >